HENDERSON MOLLY (CFO and CBO) sold 3.5% of their position (3.44K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $38.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/10/2024ACC: 0000950170-24-043385
Officer· CFO and CBO
Since Apr 2022
-3.44K
Net shares
Net seller
$38.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.44K disposed
Non-Derivative Transactions1
Common Stoock
Direct
Shares
−3.44K
Price / share
$11.10
Trade value
$38.13K
% of position
3.5%
4/8/2024
98.70K→95.26K
Total
Net shares
−3.44K
Net value
-$38.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stoock Direct | 4/8/2024 | S · Sale | −3.44K | $11.10 | $38.13K | 3.5% | 98.70K | 95.26K |
| Total | −3.44K | -$38.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.91K
Total
1.91K indirect1.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.91K | Indirect |
| Total | 1.91K | 1.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported